10:12 AM EST - AREV Nanotec Brands Inc. : Announced that AREV is utilizing its proprietary extraction technologies and facilitating initial efforts to identify broad spectrum antiviral agents derived from medicinal photochemistry sources including bioactive compounds sourced from Moringa oleifera and Moringa ovalifolia , identified in peer-reviewed publications as presenting a wide range of antiviral activity, and may demonstrate high affinity with viral protease inhibition. More than 2,100 plant species globally have the potential for being used as medical plants and it has been estimated, that plant derived drugs constitute as much as 25% of the total therapeutics while in fast developing countries such as India and China, the contribution is as much as 80%. AREV Nanotec Brands Inc.
shares C.AREV are trading down 1 cent at $0.38.
